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Abstract Oxidative stress has been connected to various
forms of cardiovascular diseases. Previously, we have been
investigating the potential of new nitrogen-containing
synthetic compounds using a neuronal cell model and
different oxidative stress conditions in order to elucidate
their potential to ameliorate neurodegenerative diseases.
Here, we intended to extend these initial studies and
investigate the protective role of four of those new syn-
thetic compounds (FMA4, FMA7, FMA762 and FMA796)
against oxidative damage induced to H9c2 cardiomyoblasts
by tert-butylhydroperoxide (t-BHP). The data indicates that
FMA762 and FMA796 decrease t-BHP-induced cell death,
as measured by both sulforhodamine B assay and nuclear
chromatin condensation evaluation, at non-toxic concen-
trations. In addition, the two mentioned compounds inhibit
intracellular signalling mechanisms leading to apoptotic
cell death, namely those mediated by mitochondria, which
was confirmed by their ability to overcome t-BHP-induced
morphological changes in the mitochondrial network, loss
of mitochondrial membrane potential, increased expression
of the pro-apoptotic proteins p53, Bax and AIF and acti-
vation of caspases-3 and -9. Importantly, our results indi-
cate that the compounds’ ROS scavenging ability plays
a crucial role in the protection profile, as a significant
decrease in t-BHP-induced oxidative stress occurred in
their presence. Data obtained indicates that some of the test
compounds may clearly prove valuable in a clinical context
by diminishing cardiac injury associated to oxidative stress
without any toxicity.
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Abbreviations
ROS Reactive oxygen species
t-BHP tert-butyl hydroperoxide
SRB Sulforhodamine B
TMRM Tetramethyl rhodamine methyl ester
Dw Membrane potential
CCCP Carbonyl cyanide m-chloro phenyl
hydrazone
AIF Apoptosis-inducing factor
CM-H2DCFDA 5-(and-6)-chloromethyl-2
0,70-
dichlorodihydrofluorescein diacetate
NBT NitroBlue Tetrazolium
fSD Intracellular fluorescence standard
deviation
Introduction
Cardiovascular diseases have been established as one of the
leading causes of death worldwide [1]. By its turn, oxida-
tive stress has been associated to various forms of cardio-
vascular diseases, including atherosclerosis, ischaemia–
reperfusion injury and other cardiomyopathies [2, 3].
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Supporting the connection between oxidative stress and
cardiac pathologies, it has been demonstrated that the
administration of exogenous antioxidants results in the
protection against oxidative myocardial injury [4, 5].
Mitochondria are recognized as the major sites of ROS
production in the cell, since about 2% of total oxygen
escapes the electron transport chain, leading to the for-
mation of superoxide radicals and subsequently other
reactive species, such as hydrogen peroxide and hydroxyl
radicals [6]. Since cardiac tissue is very abundant in
mitochondria (up to 35% of the cell volume) and the car-
diac muscle is dependent on a continuous supply of oxi-
dative phosphorylation-derived ATP [7], cardiac cells are
at a high risk of suffering oxidative damage.
The production of ROS by mitochondria seems to be
also involved in the initiation and execution of apoptotic
cell death [1] and apoptosis has been associated with
human cardiovascular system impairment [8]. ROS can
promote cytochrome c release from mitochondria to the
cytosol, probably by a mechanism involving the mito-
chondrial permeability transition (MPT) pore, which
involves swelling of the mitochondrial matrix and rupture
of the outer membrane [9]. Alternatively, cytochrome c
may also be released in a MPT-independent way, regulated
by some members of the Bcl-2 proteins’ family, with
consequent downstream activation of caspases, thus play-
ing an important role in the overall regulation of cardio-
myocyte apoptosis [10]. Therefore, pharmacological agents
that would be able to effectively suppress ROS formation
and modulate mitochondrial function, with minimal
intrinsic toxicity, should deserve a more intense investi-
gation [1, 4].
We have previously described the potential of new
nitrogen compounds from organic synthesis, against dif-
ferent conditions in which oxidative stress is involved
[11, 12]. Four of them (named FMA4, FMA7, FMA762
and FMA796) showed an elevated ROS scavenging
activity in a neuronal cell model, which resulted in lipid
peroxidation and oxidative DNA damage protection.
In the present study, the hypothesis was to extend the
benefit of these new compounds to cardiac cells, which
differ from other cell types by their antioxidant networks
[13] and their limitation in accumulating antioxidants [14].
If protection is obtained with the test compounds, new
perspectives could be open for their clinical use. Of par-
ticular interest was the assessment of their potential activity
at the mitochondrial level.
A clonal myogenic cell line derived from embryonic rat
ventricle (H9c2 cells) was used as biological model, and
the pro-oxidant tert-butylhydroperoxide (t-BHP) was cho-
sen as the oxidative stress inducer. The system has been
extensively used in the literature to study molecular
responses of cardiomyocytes to oxidative damage.
Materials and Methods
Chemicals
The test compounds used in this study (Fig. 1) were pre-
pared in the group of Organic Synthesis, Chemistry
Department, University of Minho, from the reaction of an
appropriate phenolic aldehyde with a substituted amine,
following an experimental procedure adapted from previ-
ous work [15]. The compounds were provided as a yel-
lowish powder, which was reconstituted in DMSO,
aliquoted and maintained frozen at -80C until use. Each
aliquot was thawed only once. The new molecules have a
phenol ring with hydroxyl groups (Fig. 1) that are usually
responsible for the antioxidant properties of a compound.
On the other hand, it is also known that compounds with
nitrogen groups can easily interact with active centres
responsible for different functions in living organisms.
Therefore, the association of these two moieties in the
same molecule was expected to result in new structures
with increased antioxidant potential and greater ability to
stabilize free radicals, in comparison with the molecules
traditionally used [15].
Foetal bovine serum (FBS) was obtained from Bio-
Chrom KG (Berlin, Germany); Dulbecco’s Modified
Eagle’s Medium (DMEM) cell culture medium, dimethyl
sulfoxide (DMSO), EDTA, trypsin, tert-butyl hydroper-
oxide, sulforhodamine, phenazine methosulphate (PMS),
reduced nicotinamide adenine dinucleotide (NADH),
NitroBlue Tetrazolium (NBT) and Hoechst 33342 were
purchased from Sigma–Aldrich (St. Louis, MO, USA).
Tetramethyl rhodamine methyl ester (TMRM), Calcein-
AM and 5-(and-6)-chloromethyl-20,70-dichlorodihydro-
fluorescein diacetate (CM-H2DCFDA) were obtained from
Invitrogen (Eugene, OR, USA).
H9c2 Cell Culture
H9c2 cell line was originally derived from embryonic rat
heart tissue using selective serial passages [16] and was
purchased from America Tissue Type Collection (Manassas,
VA, USA). This cell line has shown electrophysiological
and biochemical properties of both skeletal and cardiac tis-
sues, including depolarization in response to acetylcholine
and rapid activation of calcium currents through L-type
channels. They have been used extensively in the literature
as models for cardiomyoblasts and have been considered as
a proper model to study molecular responses of the cardio-
myocyte to oxidative damage [17, 18]. Cells were grown in
DMEM supplemented with 1.5 g l-1 sodium bicarbonate,
10% FBS, 100 U ml-1 of penicillin and 100 lg ml-1 of
streptomycin in 75-cm2 tissue culture flasks, and maintained
at 37C, in a humidified incubator containing 5% CO2.
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To prevent loss of differentiation potential, cells were not
allowed to become confluent. So, they were fed every
2–3 days, and sub-cultured once they reached 70–80%
confluence, by treatment with a 0.05% trypsin/EDTA solu-
tion. Cells were seeded at a density of 35000 cells per ml,
either in 24-well plates (final volume of 1 ml well-1) for
sulforhodamine B assays, or in 100 mm diameter tissue
culture dishes for Western blots. For experiments using
fluorescence microscopy, cells were seeded as described
previously, but in 6-well plates containing glass coverslips
(final volume of 2 ml medium well-1). Treatment with both
compounds in study and t-BHP was done for either 3 or 6 h,
as mentioned in the captions of figures.
Sulforhodamine B (SRB) Assay
The effects of the nitrogen compounds on cell proliferation
per se and on the protection against t-BHP-induced cell
death was evaluated by the sulforhodamine B assay,
according to Papazisis et al. [19], with slight modifications
[20]. H9c2 cells were seeded in 24-well plates and treated
with the nitrogen compounds in different time points, in the
presence or absence of t-BHP. Following this treatment,
the incubation medium was removed and cells were
washed with PBS and fixed in ice cold methanol, con-
taining 1% acetic acid, for at least 1 h. Cells were then
incubated with 0.5% (w v-1) sulforhodamine B dissolved
in 1% acetic acid for 1 h at 37C. Unbound dye was
removed by washing several times with 1% acetic acid.
Bound SRB was then solubilized with 10 mM Tris base
solution, pH 10. After shaking the plates to dissolve the
SRB, 200 ll from each well was transferred to 96-well
plates and the absorbance read at 540 nm, against a blank
containing 10 mM Tris alone. Results were expressed rel-
atively to t = 0 h, in the presence of the vehicle alone
(DMSO), which was considered as 100% of cell prolifer-
ation/cell viability.
Chromatin Condensation Detection
The morphology of cells nuclei was observed by using the
cell-permeable DNA dye Hoechst 33342. Cells presenting
nuclei homogeneously stained with the dye were consid-
ered to be normal, whereas the ones presenting chromatin
condensation were considered as apoptotic.
In brief, after being treated with the compounds in the
presence of t-BHP, cells were carefully washed with PBS,
fixed with 2 ml of ice-cold absolute methanol and stained
with 1 lg ml-1 of Hoechst 33342 for 30 min, at 37C, in
the dark. Nuclear morphological changes were detected in
a fluorescence microscope (Zeiss Axioskop 2 plus) with an
UV filter. Two hundred cells from several randomly chosen
fields were counted and the number of apoptotic cells
expressed as a percentage of the total number of cells.
Fig. 1 Schematic structure of
the newly synthesized nitrogen
compounds. A phenolic unit is
linked to an amine function
through a linear chain
containing a nitrogen atom in
three carbon atoms. FMA762
and FMA796 differ mainly from
FMA4 and FMA7 by the
presence of three hydroxyl
groups within the phenol ring,
instead of one. The compounds
were prepared by F. M. Areias,
Group of Organic Chemistry,
University of Minho
Cardiovasc Toxicol (2010) 10:51–65 53
Triple Labelling of H9c2 Cells with TMRM, Hoechst
33342 and Calcein-AM
H9c2 cellular and mitochondrial morphological changes
were analysed by fluorescence microscopy, according to
Sarda˜o et al. [20], with slight modifications. Briefly, cells
adhered to coverslips placed in the bottom of 6-well plates
and treated with the compounds in the presence of t-BHP,
were incubated with 100 nM tetramethyl rhodamine
methyl ester (TMRM), 1 lg ml-1 Hoechst 33342 and
300 nM Calcein-AM for 30 min, at 37C, in the dark.
Coverslips were then carefully removed and cells observed
under a fluorescence microscope.
Measurement of Mitochondrial Membrane Potential
(Dw)
Monitorization of the mitochondrial Dw was performed by
loading cells with TMRM, a membrane-permeable cationic
fluorophore that accumulates electrophoretically inside
mitochondria, proportionally to their Dw [21]. Thirty
minutes before the end of the 3-h incubation period with
50 lM t-BHP and the nitrogen compounds, TMRM was
added to the cell culture medium, to a final concentration of
100 nM. Cells were then visualized under a fluorescence
microscope, using the adequate filter setting. As described
elsewhere, mitochondrial TMRM labelling results into
large fluorescence standard deviation (fSD) values between
the mitochondrial bodies (high fluorescence) and cytosol
(dark background). An initial slight mitochondrial depo-
larization causes the redistribution of TMRM from mito-
chondria into the cytosol, resulting in practically no
alterations in the mean cell fluorescence value, although
the fSD is altered. A large-scale depolarization causes a
dramatic decrease in the fSD as the dye is evenly distrib-
uted throughout the cell [22]. So, in addition to cell mean
fluorescence, we have also quantified fSD for each treat-
ment, which is recognized to be a more sensitive parameter
of quantification. Both cell mean fluorescence intensity and
the fSD were quantified using ImageJ 1.40 g software
(National Institutes of Health, USA). As a test control, cells
were subjected to complete mitochondrial depolarization
by treatment with 50 lM carbonyl cyanide m-chloro phe-
nyl hydrazone (CCCP).
Preparation of Total Protein Extracts and Nuclear
Fractionation
To obtain total protein extracts, after treatment with the
compounds in the presence of t-BHP, H9c2 cells were
harvested by trypsinization and centrifuged twice at
10009g, for 5 min. Floating cells were also collected and
combined with the adhered ones. Cellular pellets were then
resuspended in 50 ll of lysis buffer (20 mM HEPES/
NaOH, pH 7.5, 250 mM Sucrose, 10 mM KCl, 2 mM
MgCl2, 1 mM EDTA) supplemented with 2 mM dithio-
threitol (DTT), 100 lM phenylmethylsulfonyl fluoride
(PMSF) and a protease inhibitor cocktail (containing
1 lg ml-1 of leupeptin, antipain, chymostatin and pepsta-
tin A). Afterwards, pellets were disrupted with *30 pas-
sages through a 27-gauge needle. The cell suspension was
then rapidly frozen/thawed three times in liquid nitrogen
and kept at -80C until use.
For the preparation of nuclear fractions, cells were
harvested as described previously and resuspended in
homogenization buffer (250 mM sucrose, 20 mM HEPES/
KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 0.1 mM
EDTA, 1 mM EGTA) supplemented with 1 mM DTT,
100 lM PMSF and protease inhibitor cocktail (containing
1 lg ml-1 of leupeptin, antipain, chymostatin and pepsta-
tin A). Cells were then homogenized in a Potter–Elvehjem
homogeniser with a Teflon pestle and the homogenate was
centrifuged at 2209g, for 5 min, at 4C. The pellet was
resuspended in 50 ll of a 250 mM sucrose/10 mM MgCl2
buffer, and the resulting suspension was carefully poured
over 500 ll of another buffer containing 350 mM sucrose/
0.5 mM MgCl2, in order to form a gradient. These gradi-
ents were then centrifuged at *12719g, for 5 min, at 4C
and the pellets resuspended in 50 ll of the 350 mM
sucrose/0.5 mM MgCl2 buffer.
The amount of protein in each sample was determined
by the Bradford method, using bovine serum albumin
(BSA) as standard.
Determination of Caspase-Like Activity
The activities of caspases 3 and 9 were assessed spectro-
photometrically by determining the cleavage of the
respective colorimetric substrate, as described by Serafim
et al. [23]. Briefly, after treating cells with the compounds
for 3 h, total protein extracts were obtained according to
the procedure described previously, and a sample volume
corresponding to 25 and 50 lg of protein for caspase-3 and
caspase-9, respectively, was added to the reaction buffer
(0.1% CHAPS, 10% Sucrose, 25 mM HEPES, pH 7.5,
supplemented with 10 mM DTT). The enzymatic reactions,
in a final volume of 200 ll, were initiated by the addition
of the colorimetric substrates Ac–DEVD–pNA, for cas-
pase-3-like protease activity, and Ac–LEHD–pNA, for
caspase-9-like protease activity, to a final concentration of
100 lM. After 2 h incubation at 37C, in the dark, 100 ll
from each sample was transferred to a 96-well plate and the
reaction product (nM lg-1 protein) measured spectropho-
tometrically at 405 nm. A calibration with known con-
centrations of p-nitroanilide (pNA) was done.
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Western-Blot Analysis
Protein expression was determined by Western-blot. Equal
amounts of protein (50 lg) were denatured in sample
loading buffer, separated in 8–15% polyacrylamide gels by
sodium dodecyl sulphate–polyacrylamide gel electropho-
resis (SDS/PAGE), and transferred to polyvinylidene
difluoride (PVDF) membranes (Amersham Biosciences,
Buckinghamshire, UK). The membranes were blocked for
2 h, at room temperature, in TPBS (PBS and 0.1% Tween
20, pH 7.4), containing 5% skim milk. Blots were then
incubated overnight, at 4C, with goat anti-p53 (1:200,
Santa Cruz Biotechnology, CA, USA), rabbit anti-Bax
(1:8000, Cell Signaling Technology, Beverly, MA, USA),
rabbit anti-AIF (1:1000, Cell Signaling Technology) or
mouse anti-b-actin (1:10000, Sigma–Aldrich, St. Louis,
MO, USA). All primary antibodies were diluted in TPBS
containing 1% BSA. After three washes, membranes were
incubated for 1 h in the presence of the horseradish per-
oxidase-conjugated anti-goat immunoglobulin (IgG) for
p53 (1:5000, DAKO Cytomation, Denmark), anti-mouse
immunoglobulin (IgG) for b-actin (1:10000, Amersham)
and anti-rabbit immunoglobulin (IgG) for the other pro-
teins (1:10000, Amersham). Immunoreactive bands were
then detected using the Immobilon chemiluminescence
detection kit (Millipore, Billerica, MA, USA). The bands
were visualized by using a molecular imager Chemi-Doc
XRS system (Bio-Rad, Hercules, CA, USA), and the
images were analysed with the Quantity One software
(Bio-Rad). Band intensity for p53, Bax and AIF was nor-
malized against the loading control b-actin.
Detection of Intracellular Reactive Oxygen Species
Intracellular ROS formation was assessed by using the non-
fluorescent probe 5-(and-6)-chloromethyl-20,70-dichlor-
odihydrofluorescein diacetate (CM-H2DCFDA), which
permeates cell membrane and becomes oxidized in the
presence of ROS, yielding the fluorescent 2,70-dichloro-
fluorescein (DCF), by a method previously described [21],
slightly modified. Briefly, after a 3-h treatment with t-BHP
and the nitrogen compounds, cells in coverslips were
incubated with 7.5 lM CM-H2DCFDA for 30 min, at
37C, in the dark. Cells were then observed by fluorescence
microscopy using a fluorescein filter in a Leica DM 4000B
microscope. The intracellular mean fluorescence intensity
was quantified using the ImageJ 1.40 g software (National
Institutes of Health, USA).
Evaluation of Superoxide Radical Scavenging Activity
The superoxide radical scavenging activity of the com-
pounds was determined in a cell-free system, by using both
a non-enzymatic and an enzymatic system, as previously
described [24], which is based on the reduction, at 560 nm,
of Nitroblue Tetrazolium (NBT) to the blue chromogen
formazan, by O2
•-.
In the non-enzymatic assay, superoxide radicals were
generated by the phenazine methosulphate (PMS)/NADH
system. Briefly, increasing concentrations of the nitrogen
compounds (1–100 lM) were added, in a 96-well plate, to
a reaction mixture consisting of 166 lM NADH and
43 lM NBT. Reactions were then initiated by the addition
of 2.7 lM PMS, to a final volume of 300 ll, and followed
spectrophotometrically for 2 min, at room temperature. All
reagents were dissolved in 19 mM phosphate buffer, pH
7.4.
In the enzymatic assay, the system xanthine/xanthine
oxidase (X/XO) was used to produce the superoxide anion.
Reaction mixtures in the wells consisted of 44 lM xan-
thine (dissolved first in 1 lM NaOH and then in 50 mM
phosphate buffer with 0.1 mM EDTA, pH 7.8), 50 lM
NBT (dissolved in 50 mM phosphate buffer with 0.1 mM
EDTA, pH 7.8) and the nitrogen compounds, tested at
different concentrations (0.25–100 lM). Enzymatic reac-
tions were initiated by the addition of 0.29 U ml-1 XO
(dissolved in 0.1 mM EDTA), to a final volume of 300 ll,
and the reduction of NBT followed spectrophotometrically
for 2 min, at room temperature.
IC50 values were determined, for each assay, from the
dose–response curves obtained for each compound, as the
concentrations required inhibiting the reduction of NBT in
50%.
Statistical Analysis
Data is expressed as the mean ± SEM, of the indicated
number of experiments. The significance of the differences
between the means observed was evaluated using the
unpaired two-tailed Student’s t-test or the one-way
ANOVA followed by the Student–Newman–Keuls post
hoc test. A difference of P B 0.05 was considered
significant.
Results
Effects of the Compounds on Cell Proliferation
The sulforhodamine B assay was used to assess the effect
of the compounds per se on cell proliferation in a time and
dose-dependent manner. As it can be observed in Fig. 2, at
the concentrations tested, none of the compounds alone
seem to affect cellular proliferation, at least up to 96 h in
culture. Despite the absence of statistical significance,
concentrations higher than 40 lM of FMA762 and
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FMA796 caused a small inhibition of cell growth, hence
those concentrations were not used in subsequent assays.
For 100 lM, there is some effect for these two compounds
in cell proliferation, although toxicity was still not
observed (data not shown).
The next step was to verify if any of the test compounds
could afford protection against the loss of cells caused by
t-BHP-induced toxicity on H9c2 cells. The thiol-oxidizing
agent t-BHP is metabolized intracellularly, generating tert-
butoxyl radicals, and has been commonly used as an
inducer of oxidative stress in several cell models, leading
among other effects to a decrease in reduced glutathione
[25, 26]. Depending on the cell line used, results obtained
have also shown that this deleterious agent may also induce
several characteristics of cell apoptosis, namely at mito-
chondrial level [6]. Based on the proliferation curves
obtained, the concentrations of compounds used in the
following experiments were chosen, namely 20 and 40 lM
for FMA4 and FMA7, and 5 and 20 lM for FMA762 and
FMA796. It should be noted that the lower concentrations
tested (20 lM for FMA4 and FMA7, and 5 lM for
FMA762 and FMA796) correspond to the approximate
IC50 values previously determined by the DPPH discol-
ouration assay. Moreover, all the concentrations chosen
had previously shown high levels of protection against
oxidative damage induced to PC12 cells [11, 12].
Data in Fig. 3 indicate that after a 6-h treatment with
t-BHP, a decrease of about 55% in cell numbers occurs, in
comparison with control cells. However, this decrease was
prevented, in a statistically significant manner, in the
presence of the compounds, except for FMA4. The pro-
tection observed with FMA762 and FMA796, besides
being more powerful, is also attained for a lower concen-
tration (5 lM). This superior protective effect of FMA762
and FMA796 against t-BHP-induced toxicity is in accor-
dance with our previous results, obtained in PC12 cells
[12].
Chromatin Condensation
Chromatin condensation is a hallmark of apoptosis. To
verify if the protection against the cytotoxicity induced by
t-BHP involves inhibition of this apoptotic phenomenon,
H9c2 cells were stained with the fluorescent probe Hoechst
33342, which binds to DNA, and visualized under an
epifluorescence microscope to quantify nuclei with typical
apoptotic morphology.
Figure 4 shows that the treatment with t-BHP leads to a
statistically significant increase in the number of nuclei with
condensed chromatin, which occurs in a time-dependent
manner. When the nitrogen compounds were co-incubated
with t-BHP, decreased numbers of apoptotic cells occurred.
Fig. 2 Cellular proliferation
assessed with the
sulforhodamine B assay. H9c2
cells proliferation was followed
up to 96 h, in the presence of
different compounds
concentrations, as indicated.
The percentage of cellular
proliferation was calculated
relatively to t = 0 h.
Proliferation in control cells (no
test compounds) was assessed in
the presence of 0.1% DMSO.
For each concentration, the
mean ± S.D. for at least three
independent experiments is
represented. No statistically
significant differences were
found between the different
concentrations shown and the
respective controls for each time
point
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Co-incubation with FMA762 and FMA796 resulted in
almost a complete inhibition in the formation of apoptotic
nuclei (Fig. 4). The data suggests that the protection
afforded by the test compounds against loss of cells (Fig. 3)
also results from inhibition of apoptosis.
Vital Imaging of H9c2 Cells Labelled with TMRM,
Hoechst 33342 and Calcein-AM
In order to identify possible morphological alterations
induced by t-BHP, a triple labelling with TMRM, Calcein-
AM and Hoechst 33342 was used. TMRM is a cationic,
mitochondrial selective probe that is accumulated by that
organelle in a membrane potential (Dw)-dependent manner.
Calcein-AM readily passes through the cell membrane of
viable cells because of its high hydrophobicity. After it
permeates into the cytoplasm, calcein-AM is hydrolyzed by
esterases to calcein, which remains inside the cells and
emits green fluorescence. Thus, the accumulation of this
probe inside the cells is indicative of membrane integrity,
since damaged cell membrane in necrotic cells prevents
calcein from accumulating intracellularly. Hoechst, as
mentioned previously, binds to DNA and is commonly
used to visualize nuclei, allowing the observation of
chromatin condensation or other nuclear alterations, in
apoptotic cells.
After the data pictured in Fig. 3, 3 h of incubation with
t-BHP was chosen in order to detect alterations that may
precede widespread cell death. Representative images in
Fig. 5 show that control (untreated cells) exhibit polarized
mitochondria distributed throughout the cytoplasm (A and
B), are strongly labelled by calcein (C) and show well-
defined nuclei, with normal chromatin distribution (D). On
the other hand, cells treated with t-BHP displayed several
morphological changes, which include a much smaller size,
resulting from rounding up (A) and loss of the mitochon-
drial polarization (B). Some cells presented other features,
such as a weak calcein labelling (C), condensed chromatin
(D) or pronounced membrane blebbing (A and C). The
morphological alterations are indicative of the induction of
apoptotic and/or necrotic events induced by t-BHP in
accordance with the literature [20]. The results also indi-
cate that among the nitrogen compounds tested only
FMA762 and FMA796 are able to prevent almost com-
pletely t-BHP-induced alterations of H9c2 cells. In fact, no
evidence of necrotic cells could be found in the cell pop-
ulations treated with FMA762 or FMA796 plus t-BHP. For
FMA4, and especially for FMA7, a slight protective effect
was also observed, although not as powerful as for
FMA762 or FMA796. These results are indicative of a
superior protective effect of FMA762 and FMA796 against
t-BHP-induced morphological changes and constitute a
Fig. 3 Effects of the
compounds on the reduction in
cell viability induced by 50 lM
t-BHP, evaluated by the
sulforhodamine B assay. H9c2
cells were incubated for 6 h in
the presence of the nitrogen
compounds and t-BHP. Results
are presented in terms of
percentage of cell viability,
determined relatively to the
control containing only 0.1%
DMSO, which was considered
as representing 100% of
viability. For each bar, the
mean ± SEM for at least three
independent experiments is
represented. ??? P B 0.001,
compared to control cells
(DMSO); ** P B 0.01,
*** P B 0.001, when compared
to 50 lM t-BHP
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strong evidence of the compounds’ role in the apoptotic
cascade of events.
Determination of the Compounds’ Effects
on Mitochondrial Membrane Potential
Changes in mitochondrial membrane potential (Dw) were
assessed after loading the cells with the membrane-per-
meable cationic fluorophore TMRM. In order to reduce the
risk of generating artefacts in the determination of fluo-
rescence intensity due to probe release to the cytosol, two
quantification parameters were used: cell mean fluores-
cence and fSD. Results in Fig. 6 (bottom panel) show that
in the presence of t-BHP there is a decrease in both
parameters relatively to control cells, which is indicative of
the depolarization of mitochondria. The simultaneous
incubation of t-BHP with the compounds FMA762 and
FMA796 significantly prevented mitochondrial depolar-
ization, as demonstrated by the values obtained in these
conditions, which are similar to the control. In addition, the
nitrogen compounds, by themselves, did not cause any
changes in the mitochondrial Dw as measured by the two
parameters. The effects obtained with CCCP, a protono-
phore that induces the collapse of mitochondrial membrane
potential [27], validated the assay. The representative
images on the top panel of the same figure illustrate the
observations described.
Results in this figure indicate that mitochondrial depo-
larization is a component of myoblast cell death induced by
t-BHP and that the compounds in study also act by pre-
serving mitochondrial transmembrane electric potential.
Assessment of Caspases-3 and -9 Activities
The loss of mitochondrial membrane potential, as well as
cell blebbing, and redistribution of lipids in the outer
plasma membrane are some of the phenotypic character-
istics of apoptotic cell death that can be mediated by
caspases activation [28].
As depicted in Fig. 7a, t-BHP induced the activation of
caspase-3, an effector caspase, as indicated by the almost
threefold increase in the cleavage of its substrate. Caspase-
3 activation seems to be mediated by the mitochondrial
apoptotic pathway, since caspase-9 activation was also
observed (Fig. 7b). Confirming previous data, FMA762
and FMA796 were able to prevent the activation of both
caspases tested in a statistically significant manner, which
is indicative of a protective role for the nitrogen com-
pounds against t-BHP-induced apoptotic cell death, par-
ticularly by an involvement in the mitochondrial cascade.
Fig. 4 Quantification of
apoptotic nuclei after labelling
cells with the fluorescent dye
Hoechst 33342. Top panel:
Representative images, obtained
by fluorescence microscopy of
Hoechst-labelled nuclei of H9c2
cells after treatment with t-BHP
and the nitrogen compounds (in
this case, only FMA762 and
FMA796 are represented) for 3
and 6 h. Arrows indicate nuclei
showing condensed chromatin,
characteristic of apoptosis.
Bottom panel: The number of
apoptotic nuclei were counted
and expressed as the percentage
of total cells counted
(approximately 200 cells per
coverslip). For each bar, the
mean ± SEM for five
independent experiments is
represented. ??? P B 0.001,
compared to respective control;
* P B 0.05, ** P B 0.01,
*** P B 0.001, compared to
50 lM t-BHP (for the
respective time period)
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Expression of Pro-Apoptotic Proteins
Given the protective effects of the compounds on casp-
ases activation (Fig. 7) and on apoptotic-like morpho-
logical changes induced by t-BHP in H9c2 cells, namely
at the mitochondrial and nuclear levels (Fig. 5), we tried
to identify more specific targets, especially proteins
known to activate apoptotic pathways, such as p53, Bax
and AIF.
As observed in Fig. 8a, t-BHP induces an increase in
the expression of the transcription factor p53, known to
lead to the expression of proteins that prevent cell divi-
sion and cause apoptosis [28]. These results are also in
accordance with data obtained by others for doxorubicin-
induced myocyte cell death [29]. This activation of p53
was significantly reversed in the presence of FMA762 and
FMA796. Likewise, the increase in Bax expression
observed in the presence of t-BHP (Fig. 8b) was also
prevented by the action of the nitrogen compounds. Bax
acts downstream of p53 and is responsible for the per-
meabilization of the outer mitochondrial membrane,
leading to the release of pro-apoptotic proteins [28].
Therefore, these results confirm that the nitrogen com-
pounds may prevent DNA damage by the pro-oxidants,
increased expression of p53 and its targets and subse-
quently the activation of the apoptotic mitochondrial
pathway.
Apoptosis may also be induced by a caspase-indepen-
dent pathway, namely by the translocation of the apop-
tosis-inducing factor (AIF) from mitochondria to the
nucleus, where it interacts with nucleic acids, causing
chromatin condensation and DNA fragmentation [30]. As
it is shown in Fig. 8c, t-BHP led to an increase in the
expression of AIF in the nuclear extracts of H9c2 cells,
which was once again significantly prevented by FMA762
and FMA796.
Fig. 5 Protection against
t-BHP—induced alterations
in cellular and mitochondrial
morphology. H9c2 cells were
incubated for 3 h in the
presence of 50 lM t-BHP with
or without the nitrogen
compounds. Cells were then
labelled with 100 nM TMRM,
300 nM Calcein-AM and
1 lg ml-1 Hoechst 33342.
Images are representative of five
independent experiments
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Measurement of Intracellular Reactive Oxygen Species
Our previous results with the same compounds in a neu-
ronal cell model have indicated their important ROS/RNS
scavenging activity. By its turn, t-BHP is a pro-oxidant
agent widely used as an inducer of oxidative stress [26, 31].
So, the effect of the compounds on t-BHP-induced oxida-
tive stress on H9c2 cells was assessed by fluorescence
microscopy, through the detection of oxidized dichloro-
fluorescein (DCF) form.
As expected, cell treatment with 50 lM t-BHP induces an
increase in intracellular oxidative stress, as demonstrated by
the increase in the cell mean fluorescence after 3 h incuba-
tion with the oxidant (Fig. 9). The fluorescence increase is
attenuated in the presence of three of the four compounds
studied, namely FMA7, FMA762 and FMA796. Once again,
in the case of FMA762 and FMA796, oxidative stress was
reduced to values similar to the control for the concentration
(20 lM) at which they proved protection in all the end-
points tested previously. These results are in agreement with
previous data obtained in PC12 cells [12].
In a cell-free system, the nitrogen compounds confirmed
their antiradical activity, namely regarding their superoxide
anion (O2
•-) scavenging ability evaluated through the use
of a non-enzymatic (PMS/NADH) and an enzymatic
(xanthine/xanthine oxidase) system to generate this radical.
As it can be observed in Fig. 10a, FMA762 and FMA796
are able to scavenge superoxide radicals generated by the
Fig. 6 Effects of the compounds on mitochondrial membrane
depolarization. Cells were loaded with 2 lM TMRM 30 min prior
to the end of the 3 h incubation in the presence of t-BHP and of the
nitrogen compounds. CCCP was used to induce the complete
depolarization of the inner mitochondrial membrane. Top panel:
Images representative of each condition. Bottom panel: quantification
of mitochondrial membrane potential, using two different parameters:
cell mean fluorescence intensity and standard deviation (referred as
fSD in the text). Each bar represents the mean ± SEM for at least
four independent experiments. ??? P B 0.001, compared to control
cells in the absence of CCCP; *** P B 0.001, compared to 50 lM
t-BHP
Fig. 7 Activities of caspases-3
(a) and -9 (b). H9c2 cells were
incubated in the presence of
both nitrogen compounds and
t-BHP for 3 h. Each bar
represents the mean ± SEM for
at least three independent
experiments. ? P B 0.05,
compared to control cells;
* P B 0.05, ** P B 0.01, in
comparison with 50 lM t-BHP
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PMS/NADH system, with IC50 values of 7.01 ± 0.80 and
15.44 ± 0.68 lM, respectively. This data was also con-
firmed by determining the effect of the nitrogen compounds
on superoxide generated by the xanthine/xanthine oxidase
system (Fig. 10b), which gave IC50 values of 1.61 ±
0.11 and 2.45 ± 0.14 lM for FMA762 and FMA796,
Fig. 8 Effects of the test compounds on the expression of the pro-
apoptotic proteins a p53, b Bax and c apoptosis-inducing factor (AIF).
Cells were treated with t-BHP and the nitrogen compounds either for
6 h (Bax and p53) or 15 h (AIF). For the analysis of Bax and p53
expression, total extracts were used, while extracts of the nuclear
fractions were prepared to assess AIF expression. p53, Bax and AIF
were identified as protein bands of 53, 20 and 57 KDa, respectively,
and their expression calculated relatively to b-actin. Each bar
represents the mean ± SEM for at least five independent experi-
ments. ?? P B 0.01, compared to control; * P B 0.05, ** P B 0.01
compared with 50 lM t-BHP
Fig. 9 Effects of the
compounds on t-BHP-induced
intracellular oxidative stress.
H9c2 cells were incubated in the
presence of t-BHP and the
nitrogen compounds for 3 h.
Increase in intracellular
oxidative stress was detected by
oxidation of the fluorescent
probe dichlorofluorescein. Top
panel: Representative images,
obtained by fluorescence
microscopy, of cells treated
with t-BHP and the nitrogen
compounds FMA762 and
FMA796. Bottom panel:
Quantification of DCF
fluorescence intensity. At least
five fields per sample were
analysed in each experiment.
For each bar is represented
the mean ± SEM for five
independent experiments.
??? P B 0.001, compared
with control, *** P B 0.001,
relatively to t-BHP
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respectively, that are of the same order of magnitude. Nev-
ertheless, this last approach, using the xanthine/xanthine
oxidase system is more suitable in a cellular context.
The results obtained by both systems indicate the ability
of the compounds to directly scavenge superoxide radicals.
The low IC50 values obtained were somewhat expected,
according to our previous work [12] and confirm the high
antioxidant activity of the nitrogen compounds.
Discussion
Oxidative stress has been reported to be involved in several
cardiomyopathies [32], namely by inducing modifications
in phospholipids and proteins, and therefore causing
abnormalities in the myocyte function.
Recently, we have been characterizing the antioxidant
potential of novel nitrogen compounds against events
where oxidative stress is involved, trying to find possible
action targets for neurodegeneration prevention. The
structures of these novel molecules yield them a superior
activity as antioxidants, in comparison with other com-
monly used molecules, such as Trolox and quercetin, as
previously described [12, 33]. In this particular study, we
evaluated the ability of the test compounds to protect
against oxidative injury on a cell model for cardiomyo-
cytes, the H9c2 cell line, with a particular interest in
finding an intracellular action target.
We observed that none of the nitrogen compounds
interfered with normal H9c2 cell proliferation at least up to
96 h. In the case of FMA762 and FMA796, this was only
observed for concentrations up to 75 lM. Nevertheless, it
should be taken into account that 75 lM is a concentration
about 20-fold higher than the IC50 values previously
determined by the DPPH discolouration assay [12] and
therefore may never be reached in vivo.
At the concentrations tested (20 lM for FMA4 and
FMA7, and 5 lM for FMA762 and FMA796) and after a
6-h incubation period, the morphological changes induced
by t-BHP to H9c2 cells did not seem to be reverted by
incubating cells with FMA4, and FMA7, which appeared to
only have a slight protective effect, since apoptosis (cells
accumulating green calcein fluorescence, but presenting
chromatin condensation and loss of mitochondrial mem-
brane potential as depicted by TMRM labelling) and
necrosis (loss of membrane integrity and decrease or
complete dissipation of mitochondrial membrane potential)
still occurred. On the other hand, in the presence of
FMA762 and FMA796, only a few apoptotic cells were
identified and no necrotic cells could be visualized, indi-
cating the higher protective action of these two compounds.
Mitochondrial membrane depolarization has been
described as one of the events that occurs as a response to
oxidant stimuli [34]. In agreement with that, we observed a
loss of mitochondrial Dw in the presence of t-BHP, as
indicated by a decrease in TMRM mean fluorescence
inside mitochondria. The evaluation of both mean fluo-
rescence intensity and the fSD parameter (according to
Brennan et al. [22]) shows that FMA762 and FMA796
were able to prevent t-BHP-induced mitochondrial depo-
larization. These results assume great relevance given the
importance of mitochondria in the regulation of intracel-
lular pathways leading to cell death. In fact, the depolar-
ization resulting from mitochondrial Dw disruption leads to
an increase in the permeability of the outer mitochondrial
membrane, which causes the release of several pro-apop-
totic factors (e.g., cytochrome c, AIF, among others) from
mitochondria [35].
Apoptosis is an active cell death process that has been
recognized as essential to the pathogenesis of cardiovas-
cular diseases [10]. In this study, the tested nitrogen
compounds, namely FMA762 and FMA796, proved their
effectiveness in preventing the activation of both caspases
Fig. 10 Effect of the nitrogen compounds on NBT reduction induced
by superoxide radical generated in a an NADH/PMS system or b a
xanthine/xanthine oxidase system. The IC50 values were calculated
from the represented curves, as the concentration needed to inhibit the
reduction of NBT by 50%. For each concentration, the mean ± SEM
is represented, considering the results obtained in at least three
different experiments
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3 and 9, involved in the mitochondria-mediated apoptotic
pathway. The results demonstrate the ability of the com-
pounds to act on the intracellular signalling cascade leading
to apoptotic cell death, most likely by preventing mito-
chondrial disruption.
It is generally accepted that the tumour suppressor
protein p53 is activated by DNA damage, leading to an
increase in the expression of genes that prevent cell divi-
sion and cause apoptosis. This may result in the activation
of pro-apoptotic Bcl-2 family members, such as Bax,
causing the permeabilization of the outer mitochondrial
membrane and subsequent activation of the above men-
tioned mitochondrial-mediated apoptotic pathway [36].
The results presented show that FMA762 and FMA796
decreased t-BHP-induced increase in p53 and Bax protein
levels, indicating that their protective effects may precede
mitochondria depolarization and subsequent activation of
caspases.
Additionally, we determined a possible action of the
compounds on the caspase-independent pathway, mediated
by the apoptosis-inducing factor (AIF). The AIF is a mito-
chondrial flavoprotein oxidoreductase that is translocated to
the cytosol and then to the nucleus, where it interacts with
nucleic acids [30]. Here, we observed an increased AIF
presence in nuclear extracts from t-BHP-treated cells, which
was prevented once again by FMA762 and FMA796. These
results suggest that the test compounds may act at different
mechanisms of apoptotic signalling. Nevertheless, the role
of the AIF on t-BHP-induced toxicity on H9c2 myoblasts is
currently under investigation.
The high compounds’ ROS scavenging properties
shown in our previous studies suggested that the protective
role of the compounds on all these events may be mediated
precisely by their ROS scavenging activity. In fact, they
were able to significantly protect H9c2 cells against intra-
cellular oxidative stress induced by t-BHP, as expected.
We obtained additional evidence for their ability to scav-
enge the superoxide anion (O2
•-) in two cell-free systems.
Although this radical is not regarded as highly reactive in a
cellular context due to its inability to cross-lipid mem-
branes, it is formed during many metabolic processes and
can easily yield more reactive species, such as hydrogen
peroxide and molecular oxygen by the action of superoxide
dismutase [32]. Therefore, the significant superoxide
scavenging activity demonstrated by the new compounds,
namely FMA762 and FMA796 (indicated by their low IC50
values), can assume great relevance.
We conclude that the new nitrogen compounds in study
clearly protect H9c2 cells against oxidative stress-induced
damage. FMA762 and FMA796, which differ from the
other two (FMA4 and FMA7) by the presence of three
hydroxyl groups within the phenol ring, revealed a superior
profile of protection, since they were able to protect cells to
a higher extent and at lower concentrations. In addition,
FMA762 and FMA796 seem to be able to interfere in the
regulation of intracellular signalling mechanisms leading to
apoptotic cell death, namely those mediated by mitochon-
dria. This was confirmed by their ability to overcome
t-BHP-induced morphological changes in the mitochon-
drial network, loss of mitochondrial membrane potential,
caspases activation and increased expression of pro-apop-
totic proteins leading to induction of both caspase-depen-
dent and -independent pathways. It is also worth noticing
that the beneficial effects occur for concentrations at which
toxicity is not apparent.
The overall results obtained with these compounds are
very promising in the context of the development of novel
antioxidant agents capable of preventing cardiac injury
directly related to free radical production. However, care
should be taken before extrapolating these results to the
clinical practice. In fact, for the past three decades, many
studies have reported several agents able to protect the
ischaemic myocardium in experimental in vitro and in vivo
models, but have failed in the translation to the clinic [37].
Differences in methodology and biology between the pre-
clinical and clinical studies may be on the basis of the
negative clinical trials [38]. Nevertheless, other studies
have already demonstrated that some of these agents,
effective in vitro, are also able to limit myocardial
ischaemia/reperfusion in humans [39, 40]. So, although this
work intended to be a first approach to evaluate the effects
of the nitrogen compounds as cardioprotectors, and further
studies (namely in animal models) need to be conducted to
determine their real effects at the myocardium level, a
potential cardioprotective role should not be discarded for
these compounds. In fact, the novel results presented in this
cardiomyocyte model represent an advance in the study of
these compounds as potential therapeutic agents, since it
widens their spectrum of action, while pointing out their
targets within the cell. Furthermore, these results can be
added up to the data collected in previous models for
neurodegenerative diseases, increasing their relevance even
further.
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